+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

Anti-Neoplastic Agents Global Market Report 2024 - Product Thumbnail Image

Anti-Neoplastic Agents Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • April 2024
  • 93 Pages
  • Global
From
From
From
From
From
From
Brain Tumor Drugs Global Market Report 2024 - Product Thumbnail Image

Brain Tumor Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Germ Cell Tumor Global Market Report 2024 - Product Thumbnail Image

Germ Cell Tumor Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Myeloproliferative Disorders Drugs Global Market Report 2024 - Product Thumbnail Image

Myeloproliferative Disorders Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more